Liu, Hui Liang |
NCT04790305: Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer |
|
|
| Recruiting | 4 | 1072 | RoW | Huaier Granule, Z20000109(NMPA Approval Number) | Fudan University, LinkDoc Technology (Beijing) Co. Ltd., Huazhong University of Science and Technology | Carcinoma Breast, Triple-negative Breast Cancer, Invasive Ductal Carcinoma, Breast | 12/27 | 07/28 | | |
NCT04504396: Safety and Efficacy of PB-119 in Subjects With Type 2 Diabetes and Not Well-controlled by Metformin Monotherapy |
|
|
| Completed | 3 | 620 | RoW | GLP-1 receptor agonist, Placebo, PB-119 Placebo | PegBio Co., Ltd. | Type 2 Diabetes Mellitus (T2DM) | 09/22 | 05/23 | | |
NCT06545747: Adaptive Hypofractionated Radiotherapy for Locally Advanced NSCLC Based on Dynamic Enhanced MRI |
|
|
| Recruiting | 3 | 304 | RoW | DCE-MRI based split-course hypo-RT, CT based split-course hypo-RT, Concurrent chemotherapy, Consolidative immunotherapy | Sun Yat-sen University | Non-small Cell Lung Cancer | 12/27 | 12/27 | | |
NCT06521255: Evaluate the Safety and Efficacy of Tafasitamab and Lenalidomide in Combination With Gemcitabine and Oxaliplatin Versus Rituximab in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma |
|
|
| Recruiting | 3 | 244 | RoW | Tafasitamab, Lenalidomide, Gemcitabine, Oxaliplatin, Rituximab | Beijing InnoCare Pharma Tech Co., Ltd. | DLBCL | 09/28 | 12/29 | | |
BELIEVE-01, NCT05234684: A Study of Orelabrutinib Plus R-CHOP in Treatment-naïve Patients With MCD Subtype Diffuse Large B-cell Lymphoma |
|
|
| Recruiting | 3 | 150 | RoW | Orelabrutinib + R-CHOP, ICP-022+ R-CHOP, Placebo + R-CHOP | Beijing InnoCare Pharma Tech Co., Ltd. | Diffuse Large B Cell Lymphoma (DLBCL) | 07/24 | 12/25 | | |
BRUIN CLL-313, NCT05023980: A Study of Pirtobrutinib (LOXO-305) Versus Bendamustine Plus Rituximab (BR) in Untreated Patients With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) |
|
|
| Active, not recruiting | 3 | 250 | Europe, Japan, US, RoW | Pirtobrutinib, LOXO-305, LY3527727, Bendamustine, Treanda, Treakisym, Ribomustin, Levact, Rituximab, Rituxan, MabThera, Truxima, Riabni, Ruxience | Loxo Oncology, Inc., Eli Lilly and Company | Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | 04/25 | 08/26 | | |
NCT06734702: Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunotherapy for Locally Advanced Non-small Cell Lung Cancer |
|
|
| Recruiting | 3 | 300 | RoW | Neoadjuvant therapy, Concurrent chemoradiotherapy, Consolidative immunotherapy | Sun Yat-sen University | Neoadjuvant Therapy, Concurrent Chemoradiotherapy, Immunotherapy, Locally Advanced Non-Small Cell Lung Cancer | 11/28 | 11/28 | | |
NCT05438875: The Combination of ATRA and Eltrombopag as the Treatment of Steroid-resistant/Relapse ITP Based on MSC-C5b-9 |
|
|
| Recruiting | 3 | 96 | RoW | all-trans retinoic acid, retinoic acid, Eltrombopag, TPO-RA | Peking University People's Hospital, Beijing Friendship Hospital, Beijing Tongren Hospital, Beijing Hospital, Navy General Hospital, Beijing | Purpura, Thrombocytopenic, Idiopathic | 12/24 | 03/25 | | |
GASTO-1074, NCT04980716: Early Specialized Cardiovascular Intervention Based on Impedance Cardiography in Locally Advanced Non-small Cell Lung Cancer Patients |
|
|
| Recruiting | 3 | 524 | RoW | Multiple cardiovascular drugs related to "Golden Triangle" | Sun Yat-sen University | Non-small Cell Lung Cancer, Cardiovascular Complication | 01/26 | 07/26 | | |
GASTO 1017, NCT03006575: Study of Split-course Chemoradiotherapy For Postoperative Locoregional Recurrence Of Non-small Cell Lung Cancer |
|
|
| Recruiting | 2 | 57 | RoW | split-course radiotherapy, concurrent chemotherapy | Sun Yat-sen University | Non-small Cell Lung Cancer | 06/20 | 07/21 | | |
NCT02337712: Once-daily Simultaneous Modulated Accelerated Thoracic Radiotherapy in Limited Small-cell Lung Cancer |
|
|
| Active, not recruiting | 2 | 198 | RoW | q.d. RT, b.i.d.RT, etoposide and cisplatin | Sun Yat-sen University | Small Cell Lung Cancer | 09/20 | 12/21 | | |
NCT04610970: A Study of TQ-B3525 in Subjects With Relapse/Refractory Diffuse Large B-cell Lymphoma (DLBCL) |
|
|
| Recruiting | 2 | 93 | RoW | TQ-B3525 tablets | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Diffuse Large B-cell Lymphoma | 03/22 | 06/22 | | |
GASTO-1066, NCT04524299: Study of Radiotherapy Combined With Albumin Bound Paclitaxel and Nedaplatin for Locally Advanced NSCLC |
|
|
| Recruiting | 2 | 160 | RoW | chest radiation(IMRT), Concurrent chemotherapy twice a week, Concurrent chemotherapy once a week | Sun Yat-sen University | Non-small Cell Lung Cancer | 05/22 | 05/24 | | |
GASTO 1052, NCT04212052: Split-course Hypofractionated Radiotherapy With Concurrent Chemotherapy in Locally Advanced Non-small Cell Lung Cancer |
|
|
| Completed | 2 | 104 | RoW | split-course radiotherapy, concurrent chemotherapy, consolidation immunotherapy | Sun Yat-sen University | Non-small Cell Lung Cancer | 01/23 | 12/23 | | |
NCT04787328: A Study of HA121-28 Tablets in Patients With Medullary Thyroid Carcinoma (MTC) |
|
|
| Recruiting | 2 | 30 | RoW | HA121-28 tablets | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Medullary Thyroid Carcinoma | 03/23 | 03/25 | | |
GASTO-1053, NCT04345146: Bevacizumab Combined With Fractionated Stereotactic Radiotherapy for 1 to 10 Brain Metastases From NSCLC |
|
|
| Completed | 2 | 100 | RoW | FSRT combined with Bevacizumab | Sun Yat-sen University | Non-small Cell Lung Cancer | 03/23 | 03/23 | | |
| Completed | 2 | 55 | RoW | Unity-based MR-Linac guided FSRT | Sun Yat-sen University | Non-small Cell Lung Cancer | 07/24 | 07/24 | | |
GASTO-1098, NCT06139419: The Impact of Thymosin α-1 on the Efficacy of Concurrent Chemoradiotherapy Followed by Immunotherpay Consolidation for Locally Advanced NSCLC |
|
|
| Recruiting | 2 | 114 | RoW | definitive radiotherapy, induction chemo-immunotherapy, albumin-bound paclitaxel, cisplatin, tislelizumab, concurrent chemotherapy, Immunotheapy consolidation, Thymosin Alpha1, thymalfasin | Sun Yat-sen University | Non-small Cell Lung Cancer | 08/25 | 08/26 | | |
GASTO-1042, NCT03663764: Hypofractionated Chemoradiotherapy and Thymosin α1 in Unresectable or Recurrent Thymic Epithelial Tumor |
|
|
| Active, not recruiting | 2 | 57 | RoW | Thymosin a1, hypofractionated radiotherapy, concurrent chemoradiotherapy | Sun Yat-sen University | Thymoma and Thymic Carcinoma | 08/23 | 08/23 | | |
| Recruiting | 2 | 59 | RoW | Unity-based MR-Linac guided Radiotherapy | Sun Yat-sen University | Mediastinal Tumor | 10/23 | 10/23 | | |
GASTO-1091, NCT04085250: Study of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy |
|
|
| Active, not recruiting | 2 | 264 | RoW | Neoadjuvant therapy, Chemotherapy concurrent with radiotherapy, Radiotherapy, Nivolumab, Observation | Sun Yat-sen University | Stage III Non-small-cell Lung Cancer | 01/25 | 01/25 | | |
GASTO-10107, NCT06281886: Induction Immuno-chemotherapy and Concurrent Chemoradiotherapy With or Without Apatinib in Unresectable, Locally Advanced Esophageal Squamous Cell Carcinoma |
|
|
| Recruiting | 2 | 170 | RoW | Induction Immunotherapy-Toripalimab, Induction Chemotherapy-Albumin-paclitaxel combined with cisplatin, Radiotherapy, Apatinib, Capecitabine, Chemotherapy concurrently with radiotherapy | Sun Yat-sen University | Esophageal Squamous Cell Carcinoma, Efficacy, Toxicity | 12/26 | 12/26 | | |
NCT06176235: Teriflunomide Plus High-dose Dexamethasone as First-line Treatment in Newly Diagnosed Primary Immune Thrombocytopenia |
|
|
| Recruiting | 2 | 132 | RoW | Teriflunomide, AUBAGIO, Dexamethasone | Peking University People's Hospital, Beijing Luhe Hospital, Chinese PLA General Hospital, Navy General Hospital, Beijing, Beijing Hospital, Beijing Friendship Hospital, Peking University First Hospital, Peking University Third Hospital, China-Japan Friendship Hospital, Beijing Tsinghua Changgeng Hospital | Immune Thrombocytopenia | 12/24 | 05/25 | | |
GASTO-1071, NCT04844385: Toripalimab Plus Neoadjuvant Chemotherapy Combined With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma |
|
|
| Active, not recruiting | 2 | 124 | RoW | Toripalimab, Paclitaxel-albumin, Nedaplatin, radiation therapy at a total dose 60 Gy, Capecitabine, radiation therapy at a total dose 50 Gy | Sun Yat-sen University | Esophageal Squamous Cell Carcinoma | 12/24 | 12/24 | | |
GASTO-1079, NCT04970693: A Study of Furmonertinib Combined With Radiotherapy for Non-small Cell Lung Cancer With Oligoprogression |
|
|
| Recruiting | 2 | 64 | RoW | Furmonertinib, Radiotherapy | Sun Yat-sen University | Non-small Cell Lung Cancer, Oligoprogressive | 01/24 | 05/24 | | |
GASTO-1086, NCT05468242: Study of Tislelizumab for Locally Advanced Non-Small Cell Lung Cancer Following Neoadjuvant Chemotherapy Plus Tislelizumab ± Bevacizumab and Definitive Concurrent Chemoradiation Therapy |
|
|
| Recruiting | 2 | 116 | RoW | Neoadjuvant chemo-immunotherapy, Bevacizumab, Radiotherapy, Tislelizumab | Sun Yat-sen University | Stage III Non-small Cell Lung Cancer | 12/24 | 12/24 | | |
NCT06582940: Elimination of PTV Margins Based on MRI-guided Adaptive Stereotactic Radiotherapy for Non-small Cell Lung Cancer With Brain Metastasis |
|
|
| Recruiting | 2 | 168 | RoW | MRI-guided adaptive SRT, Conventional SRT | Sun Yat-sen University | MRI-guided Adaptive Radiotherapy, Non-small Cell Lung Cancer, Brain Metastasis | 03/26 | 03/26 | | |
NCT06542159: Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Early-stage Non-small Cell Lung Cancer or Pulmonary Oligometastases |
|
|
| Recruiting | 2 | 130 | RoW | Online adaptive SBRT, Conventional SBRT | Sun Yat-sen University | Adaptive Radiotherapy, Stereotactic Body Radiotherapy, Non-small Cell Lung Cancer, Lung Oligometastases, Toxicity | 04/27 | 04/28 | | |
NCT05932524: Low-dose Baricitinib Plus High-dose Dexamethasone for Patients With Newly Diagnosed Immune Thrombocytopenia |
|
|
| Recruiting | 2 | 132 | RoW | Baricitinib 2 MG, Olumiant, Dexamethasone, HD-DXM | Peking University People's Hospital, Beijing Luhe Hospital, Chinese PLA General Hospital, Navy General Hospital, Beijing, Beijing Hospital, Beijing Friendship Hospital, Peking University First Hospital, Peking University Third Hospital, China-Japan Friendship Hospital, Beijing Tsinghua Changgeng Hospital | Immune Thrombocytopenia | 06/24 | 06/25 | | |
NCT06439381: Long-term Safety and Efficacy of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps |
|
|
| Recruiting | 2 | 120 | RoW | 300mg/600mg of TQH2722 injection | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Chronic Rhinosinusitis | 10/25 | 11/25 | | |
NCT05852847: Low-dose Baricitinib Plus Danazol for Steroid-resistant/Relapse Immune Thrombocytopenia |
|
|
| Recruiting | 2 | 216 | RoW | Baricitinib 2 MG [Olumiant], Olumiant, Danazol | Peking University People's Hospital, Beijing Luhe Hospital, Chinese PLA General Hospital, Navy General Hospital, Beijing, Beijing Hospital, Beijing Friendship Hospital, Peking University First Hospital, Peking University Third Hospital, China-Japan Friendship Hospital, Beijing Tsinghua Changgeng Hospital | Immune Thrombocytopenia | 11/24 | 05/25 | | |
NCT06719700: Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer |
|
|
| Recruiting | 2 | 47 | RoW | Chemotherapy, Immunotherapy, Angio-immuno kinase inhibitor, radiotherapy, Prophylactic Cranial Irradiation, Consolidation Therapy with Toripalimab and Surufatinib | Sun Yat-sen University | Toripalimab, Surufatinib, Chemoradiotherapy, Limited-stage Small Cell Lung Cancer (LS-SCLC) | 11/28 | 11/28 | | |
| Recruiting | 2 | 35 | RoW | thoracic irradiation, Concurrent chemotherapy | Sun Yat-sen University | Loco-regionally Recurrent NSCLC After Thoracic Radiotherapy | 02/25 | 02/25 | | |
NCT06089278: A Clinical Study of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps. |
|
|
| Recruiting | 2 | 160 | RoW | 300mg of TQH2722 injection, 600mg of TQH2722 injection, TQH2722 injection matching placebo | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | Sinusitis | 05/25 | 05/25 | | |
| Active, not recruiting | 1/2 | 121 | RoW | CAR-BCMA T Cells | CARsgen Therapeutics Co., Ltd., Beijing Chao Yang Hospital, The First Affiliated Hospital of Soochow University, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Tianjin Medical University General Hospital, First Affiliated Hospital of Zhejiang University, Beijing Hospital, Shanghai Tongji Hospital, Tongji University School of Medicine, First Affiliated Hospital of Wenzhou Medical University, Xiangya Hospital of Central South University, Peking University People's Hospital, Qilu Hospital of Shandong University, Sun Yat-sen University, First Affiliated Hospital, Sun Yat-Sen University | Multiple Myeloma | 12/24 | 12/25 | | |
NCT06083701: Phase I/II Study of Linperlisib Plus Chidamide for R/R Peripheral T-cell Lymphoma: a Prospective, Multi-center Study |
|
|
| Recruiting | 1/2 | 32 | RoW | Linperlisib in combined with Chidamide | Peking Union Medical College Hospital | Peripheral T Cell Lymphoma | 09/24 | 09/25 | | |
NCT05441761: Mitoxantrone Hydrochloride Liposomes in Combination With GDP in Relapsed/Refractory PTCL |
|
|
| Recruiting | 1/2 | 60 | RoW | liposomal mitoxantrone hydrochloride, gemcitabine, dexamethasone, and cisplatin | Peking Union Medical College Hospital, CSPC Ouyi Pharmaceutical Co., Ltd. | Treatment, Peripheral T-cell Lymphoma | 05/25 | 05/25 | | |
NCT04850560: Sequential Low-dose Decitabine With PD-1/CD28 CD19 CAR-T in Relapsed or Refractory B-cell Lymphoma |
|
|
| Recruiting | 1 | 30 | RoW | CD19 PD-1/CD28 CAR-T Plus Low Dose Decitabine | Second Affiliated Hospital, School of Medicine, Zhejiang University | Objective Response Rate | 05/22 | 05/24 | | |
NCT04537442: Clinical Study to Evaluate the Safety and Efficacy of IM21 CAR-T Cells in the Treatment of Elderly Patients With Relapsed or Refractory Multiple Myeloma |
|
|
| Recruiting | 1 | 10 | RoW | IM21 CAR-T cells | Beijing Immunochina Medical Science & Technology Co., Ltd. | Multiple Myeloma | 12/22 | 03/23 | | |
| Completed | 1 | 18 | RoW | Hypofractionated radiotherapy, Concurrent chemotherapy, Consolidation immunotherapy | Sun Yat-sen University | Locally Advanced Lung Carcinoma | 03/23 | 09/23 | | |
NCT04521686: Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations |
|
|
| Active, not recruiting | 1 | 200 | Europe, Japan, US, RoW | LY3410738, Gemcitabine, LY188011, Cisplatin, Durvalumab | Eli Lilly and Company, Loxo Oncology, Inc. | Cholangiocarcinoma, Chondrosarcoma, Glioma, Any Solid Tumor | 07/23 | 05/25 | | |
NCT06310590: Safety and Efficacy of NRT6003 in Patients With Unresectable Hepatocellular Carcinoma |
|
|
| Recruiting | 1 | 40 | RoW | NRT6003 Injection, Yttrium-90 carbon microspheres | Chengdu New Radiomedicine Technology Co. LTD. | Unresectable Hepatocellular Carcinoma | 10/25 | 10/25 | | |
GASTO-10102, NCT06020885: Fraction Dose Escalation of Split-course Hypofractionated Concurrent Chemoradiotherapy Following Induction Chemo-immunotherapy in Unresectable Locally Advanced Esophageal Squamous Carcinoma: a Phase I Study. |
|
|
| Recruiting | 1 | 18 | RoW | Split-course hypo-CCRT, Induction chemo-immunotherapy, Concurrent chemotherapy | Sun Yat-sen University | Esophageal Squamous Cell Carcinoma | 01/24 | 07/24 | | |
IR2022000371, NCT05453669: Clinical Study of the Efficacy of CD19-CAR-DNT Cells in the Treatment of Relapsed/Refractory B-cell NHL |
|
|
| Recruiting | 1 | 12 | RoW | CD19-CAR-DNT cells | Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Ruijiamei Biotechnologies, Co., Ltd. | B-cell Non-Hodgkin's Lymphoma | 06/24 | 06/25 | | |
NCT05924750: A Study of BL-M11D1 in Patients With Relapsed/Refractory Acute Myeloid Leukemia |
|
|
| Recruiting | 1 | 26 | RoW | BL-M11D1 | Sichuan Baili Pharmaceutical Co., Ltd. | Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) | 08/25 | 08/25 | | |
GASTO-10108, NCT06277388: Evaluation of Impedance Cardiography for Assessing Hemodynamic Shifts in Patients With LA-NSCLC During Treatment. |
|
|
| Recruiting | N/A | 237 | RoW | Impedance cardiography | Sun Yat-sen University | Non-small Cell Lung Cancer, Cardiac Toxicity | 06/25 | 06/25 | | |
GASTO-1067, NCT04654234: Total-body PET/CT Imaging Using the uEXPLORER in Non-small Cell Lung Cancer Patients Treated by Induction Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiotherapy |
|
|
| Completed | N/A | 15 | RoW | Total body PET/CT (uExplorer) | Sun Yat-sen University | Non-small Cell Lung Cancer | 12/23 | 12/23 | | |
NCT05278507: Comparing Arrow PICC Catheters w/ Arrowga+rd Blue Advanced Protection Performance and Safety to Unprotected PICC's |
|
|
| Recruiting | N/A | 444 | RoW | Arrowga+rd Blue Advance Protection PICC Placement, Sham Comparator PICC placement | Teleflex | Peripherally Inserted Central Catheter | 06/23 | 06/23 | | |
NCT04921774: Research on Patients With Heart Transplantation |
|
|
| Active, not recruiting | N/A | 100 | RoW | | Guangdong Provincial People's Hospital | Heart Transplant Rejection | 12/23 | 12/23 | | |
NCT06727669: Longitudinal Cohort of Thrombosis and Hemostasis Diseases |
|
|
| Recruiting | N/A | 3000 | RoW | | Peking University People's Hospital | Immune Thrombocytopenia, Thrombotic Thrombocytopenic Purpura, Hemophilia A, Acquired, Disseminated Intravascular Coagulation, Thrombophilia, Deep Vein Thrombosis, Pulmonary Embolism, Thrombotic Microangiopathies, Coagulation Factor Deficiency, Hemophilia A, Hemophilia B, Hemophilia B, Acquired, Platelet Dysfunction, Arterial Thromboembolism, Bleeding Disorder, Thrombosis | 12/29 | 12/30 | | |
| Recruiting | N/A | 80 | RoW | Tyrosine kinase inhibitor drugs., TKI treatment | Fujian Cancer Hospital | Thyroid Cancer, Tyrosine Kinase Inhibitor, Health Related Quality of Life | 01/25 | 01/26 | | |
NCT05647850: Optimization and Clinical Study of Early Prediction Model for Neonatal Acute Respiratory Distress Syndrome |
|
|
| Recruiting | N/A | 2000 | RoW | No intervention | University-Town Hospital of Chongqing Medical University | Neonatology | 12/25 | 12/25 | | |
NCT06019455: The Level of Patient Participation in Lung and Esophageal Cancer Patients Treated With Definitive Radiochemotherapy. |
|
|
| Recruiting | N/A | 500 | RoW | | Sun Yat-sen University | Lung Cancer, Esophageal Cancer | 05/27 | 05/27 | | |
| Not yet recruiting | N/A | 63 | NA | Zeus Cloud TPS V1.0, Eclipse | Sun Yat-sen University, The First Affiliated Hospital of Soochow University, The Affilicated Suzhou Science and Technology Town Hospital | Radiotherapy | 10/22 | 10/22 | | |
Zhou, Wei |
NCT06288334: Exploration of the Optimal Dosage of Cetirizine in the Treatment of Allergic Diseases in Chinese Children |
|
|
| Recruiting | 4 | 80 | RoW | 1-3 Cetirizine Pharmacokinetic samples | Peking University Third Hospital | Allergic Disease, Children | 03/24 | 05/24 | | |
NCT06508983: A Clinical Study Comparing SG301 Plus Pomalidomide and Dexamethasone to Placebo Plus Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma Patients |
|
|
| Recruiting | 3 | 360 | RoW | SG301 Injection, SG301 placebo, pomalidomide, dexamethasone | Hangzhou Sumgen Biotech Co., Ltd. | Relapsed/Refractory Multiple Myeloma | 03/27 | 03/28 | | |
TRAPP, NCT05811676: Tranexamic Acid for the Prevention of Postpartum Hemorrhage in Pregnant Women with Placenta Previa |
|
|
| Recruiting | 3 | 1680 | RoW | Tranexamic acid, 0.9% sodium chloride | Guangzhou Medical University, Dongguan Maternal and Child Health Care Hospital, Foshan Women and Children Hospital, BoAi Hospital of Zhongshan, Women and Children's Hospital of Chongqing Medical University, Tianjin Central Hospital of Gynecology Obstetrics, Shandong Provincial Maternal and Child Health Care Hospital Affiliated to Qingdao University, Jinan, Urumqi Maternal and Child Health Care Hospital, Zhuhai Women and Children's Hospital, The First Affiliated Hospital of Zhengzhou University, Hunan Provincial Maternal and Child Health Care Hospital, Dalian women and children's medical group, Nanfang Hospital, Southern Medical University, Huadu District People's Hospital of Guangzhou, Northwest Women's and Children's Hospital, Xi'an, Shaanxi, First Affiliated Hospital, Sun Yat-Sen University, Shenzhen Maternity & Child Healthcare Hospital, Shenzhen Baoan Women's and Children's Hospital, Dongguan People's Hospital, First Affiliated Hospital of Xinjiang Medical University, Tongji Hospital, Peking Union Medical College, Peking University First Hospital, The First Affiliated Hospital of Guangzhou Medical University, Second Affiliated Hospital of Guangzhou Medical University, Fifth Affiliated Hospital of Guangzhou Medical University, Shijiazhuang Obstetrics and Gynecology Hospital | Hemorrhage, Postpartum, Placenta Previa | 02/25 | 04/25 | | |
| Not yet recruiting | 3 | 386 | US | Home Based Exercise, Nitrate Rich Beetroot Juice, Attention Control, Placebo Beetroot Juice Without Nitrate | Northwestern University | Peripheral Artery Disease, Intermittent Claudication, Peripheral Vascular Disease, Mobility Limitation, Revascularization | 02/32 | 08/32 | | |
CREST-H, NCT03121209: Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial - Hemodynamics |
|
|
| Active, not recruiting | 3 | 385 | Canada, US | Revascularization, Intensive Medical Management (IMM) alone | Columbia University, National Institute of Neurological Disorders and Stroke (NINDS), Mayo Clinic, University of Alabama at Birmingham, University of Maryland, University of California, Los Angeles | Internal Carotid Artery Stenosis, Cognitive Impairment | 01/27 | 07/27 | | |
NCT04892498: Hypofractionated Radiotherapy Combined With PD-1 Inhibitor Sequential GM-CSF and IL-2 for the Treatment of Advanced Refractory Solid Tumors (PRaG2.0) |
|
|
| Recruiting | 2 | 66 | RoW | Hypofractionated radiotherapy, PD-1 inhibitor, GM-CSF, IL-2 | Second Affiliated Hospital of Soochow University | Advanced Refractory Solid Tumors | 08/23 | 08/24 | | |
NCT05765825: Study of Low-Dose Radiotherapy Concurrent Chemotherapy With Serplulimab for Patients With ES-SCLC |
|
|
| Recruiting | 2 | 61 | RoW | serplulimab, HLX10, Cisplatin, Cisplatin injection, Carboplatin, Carboplatin injection, Etoposide, Etoposide injection, Thoracic radiation therapy (TRT), low-dose radiotherapy | Sichuan University | Extensive-stage Small-cell Lung Cancer | 06/24 | 12/25 | | |
NCT06700421: Phase II Clinical Study of Adebrelimab Combined with Apatinib in the Treatment of Locally Advanced Non-small Cell Lung Cancer Patients with Radiation Pneumonitis |
|
|
| Active, not recruiting | 2 | 32 | RoW | Adebrelimab + Apatinib, immunotherapy, Programmed death ligand 1 inhibitor, Antiangiogenic agents | Wei Zhou | Unresectable Locally Advanced Non-small Cell Lung Cancer | 12/24 | 12/26 | | |
NCT06366373: Reducing Stigma Through a Mental Health Art Exhibition and Its Printed Brochure |
|
|
| Recruiting | N/A | 360 | RoW | A mental health art exhibition, printed or online education materials | Hunan University, Central South University, Qixi Charity | Mental Health Issue | 05/25 | 05/25 | | |
GM-seq, NCT05415670: Benign/Malignant Pulmonary Nodule Classification Based on High-throughput Whole-genome Methylation Sequencing |
|
|
| Recruiting | N/A | 120 | RoW | Whole-genome Methylation Sequencing(GM-seq) | Geneplus-Beijing Co. Ltd., Beijing Hospital, Emergency General Hospital | Pulmonary Nodule, Solitary, Whole-genome Methylation Sequencing | 06/25 | 06/25 | | |
NCT06481566: Efficacy and Safety of Almonertinib Combined With Stereotactic Body Radiotherapy (SBRT) in the Treatment of Non-small Cell Lung Cancer With EGFR Sensitive Mutation: a Single-arm, Open-label Clinical Trial |
|
|
| Recruiting | N/A | 30 | RoW | stereotactic ablative body radiotherapy | Chongqing University Cancer Hospital | Non-small Cell Lung Cancer | 01/26 | 06/26 | | |
NCT03647852: Clinical Study on Strategy for Refractory Henoch-Schönlein Purpura |
|
|
| Recruiting | N/A | 150 | RoW | Methylprednisolone, IVIG, other basic supportive treatment | Children's Hospital of Fudan University, Shanghai Children's Hospital, Shanghai Children's Medical Center | Henoch-Schönlein Purpura | 10/24 | 10/25 | | |
| Recruiting | N/A | 200 | US | SelfWrap Bioabsorbable Perivascular Wrap, SelfWrap, Untreated AVF Control, Standard of Care | VenoStent | Chronic Kidney Diseases, End Stage Renal Disease, Arteriovenous Fistula, Hemodialysis Access Failure, ESRD, Vascular Access Complication, Renal Failure, Catheter Complications, Catheter Dysfunction, Renal Insufficiency | 06/25 | 12/27 | | |
CREST-2, NCT02089217: Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial |
|
|
| Active, not recruiting | N/A | 2486 | Europe, Canada, US, RoW | Carotid endarterectomy (CEA), Carotid Stenting (CAS), Intensive Medical Management - no CEA, Intensive Medical Management - no CAS | Thomas G. Brott, M.D., National Institute of Neurological Disorders and Stroke (NINDS) | Carotid Stenosis | 02/26 | 02/26 | | |
| Recruiting | N/A | 450 | US | Alto Abdominal Stent Graft System, FDA Approved EVAR AAA Graft Systems | Endologix | AAA, AAA - Abdominal Aortic Aneurysm | 12/28 | 12/28 | | |
Qi, Hongbo bo |
TRAPP, NCT05811676: Tranexamic Acid for the Prevention of Postpartum Hemorrhage in Pregnant Women with Placenta Previa |
|
|
| Recruiting | 3 | 1680 | RoW | Tranexamic acid, 0.9% sodium chloride | Guangzhou Medical University, Dongguan Maternal and Child Health Care Hospital, Foshan Women and Children Hospital, BoAi Hospital of Zhongshan, Women and Children's Hospital of Chongqing Medical University, Tianjin Central Hospital of Gynecology Obstetrics, Shandong Provincial Maternal and Child Health Care Hospital Affiliated to Qingdao University, Jinan, Urumqi Maternal and Child Health Care Hospital, Zhuhai Women and Children's Hospital, The First Affiliated Hospital of Zhengzhou University, Hunan Provincial Maternal and Child Health Care Hospital, Dalian women and children's medical group, Nanfang Hospital, Southern Medical University, Huadu District People's Hospital of Guangzhou, Northwest Women's and Children's Hospital, Xi'an, Shaanxi, First Affiliated Hospital, Sun Yat-Sen University, Shenzhen Maternity & Child Healthcare Hospital, Shenzhen Baoan Women's and Children's Hospital, Dongguan People's Hospital, First Affiliated Hospital of Xinjiang Medical University, Tongji Hospital, Peking Union Medical College, Peking University First Hospital, The First Affiliated Hospital of Guangzhou Medical University, Second Affiliated Hospital of Guangzhou Medical University, Fifth Affiliated Hospital of Guangzhou Medical University, Shijiazhuang Obstetrics and Gynecology Hospital | Hemorrhage, Postpartum, Placenta Previa | 02/25 | 04/25 | | |
He, Fang |
NCT06111079: Aspirin Discontinuation in High-Risk Pregnant Women of Preeclampsia |
|
|
| Recruiting | 3 | 1800 | RoW | aspirin discontinuation, initiation of aspirin in early pregnancy, aspirin continuation | FANG HE | Preeclampsia, Perinatal Haemorrhage | 12/24 | 12/24 | | |
TRAPP, NCT05811676: Tranexamic Acid for the Prevention of Postpartum Hemorrhage in Pregnant Women with Placenta Previa |
|
|
| Recruiting | 3 | 1680 | RoW | Tranexamic acid, 0.9% sodium chloride | Guangzhou Medical University, Dongguan Maternal and Child Health Care Hospital, Foshan Women and Children Hospital, BoAi Hospital of Zhongshan, Women and Children's Hospital of Chongqing Medical University, Tianjin Central Hospital of Gynecology Obstetrics, Shandong Provincial Maternal and Child Health Care Hospital Affiliated to Qingdao University, Jinan, Urumqi Maternal and Child Health Care Hospital, Zhuhai Women and Children's Hospital, The First Affiliated Hospital of Zhengzhou University, Hunan Provincial Maternal and Child Health Care Hospital, Dalian women and children's medical group, Nanfang Hospital, Southern Medical University, Huadu District People's Hospital of Guangzhou, Northwest Women's and Children's Hospital, Xi'an, Shaanxi, First Affiliated Hospital, Sun Yat-Sen University, Shenzhen Maternity & Child Healthcare Hospital, Shenzhen Baoan Women's and Children's Hospital, Dongguan People's Hospital, First Affiliated Hospital of Xinjiang Medical University, Tongji Hospital, Peking Union Medical College, Peking University First Hospital, The First Affiliated Hospital of Guangzhou Medical University, Second Affiliated Hospital of Guangzhou Medical University, Fifth Affiliated Hospital of Guangzhou Medical University, Shijiazhuang Obstetrics and Gynecology Hospital | Hemorrhage, Postpartum, Placenta Previa | 02/25 | 04/25 | | |
NCT05374252: Chemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma Patients |
|
|
| Recruiting | 3 | 102 | RoW | PD-1 inhibitor, radiation, concurrent chemotherapy, concurrent chemoradiotherapy | Sixth Affiliated Hospital, Sun Yat-sen University | Anal Canal Cancer Stage III, Anal Squamous Cell Carcinoma, Anal Canal Cancer, Anal Cancer | 05/25 | 12/25 | | |
NCT06383858: The Project of Gestational Hypertension and Preeclampsia Screening and Prevention Center |
|
|
| Recruiting | N/A | 50000 | RoW | Screening method | The Third Affiliated Hospital of Guangzhou Medical University | Preeclampsia, Maternal Deaths | 12/28 | 12/28 | | |
NCT06339749: Pregnancy Outcomes in Normotensive VS stage1 Hypertension: a Prospective Observational Study |
|
|
| Recruiting | N/A | 626 | RoW | blood pressure, Clinical protocols for preeclampsia risk screening | FANG HE | stage1 Hypertension, Preeclampsia | 06/25 | 02/26 | | |
Zhong, Qimei |
TRAPP, NCT05811676: Tranexamic Acid for the Prevention of Postpartum Hemorrhage in Pregnant Women with Placenta Previa |
|
|
| Recruiting | 3 | 1680 | RoW | Tranexamic acid, 0.9% sodium chloride | Guangzhou Medical University, Dongguan Maternal and Child Health Care Hospital, Foshan Women and Children Hospital, BoAi Hospital of Zhongshan, Women and Children's Hospital of Chongqing Medical University, Tianjin Central Hospital of Gynecology Obstetrics, Shandong Provincial Maternal and Child Health Care Hospital Affiliated to Qingdao University, Jinan, Urumqi Maternal and Child Health Care Hospital, Zhuhai Women and Children's Hospital, The First Affiliated Hospital of Zhengzhou University, Hunan Provincial Maternal and Child Health Care Hospital, Dalian women and children's medical group, Nanfang Hospital, Southern Medical University, Huadu District People's Hospital of Guangzhou, Northwest Women's and Children's Hospital, Xi'an, Shaanxi, First Affiliated Hospital, Sun Yat-Sen University, Shenzhen Maternity & Child Healthcare Hospital, Shenzhen Baoan Women's and Children's Hospital, Dongguan People's Hospital, First Affiliated Hospital of Xinjiang Medical University, Tongji Hospital, Peking Union Medical College, Peking University First Hospital, The First Affiliated Hospital of Guangzhou Medical University, Second Affiliated Hospital of Guangzhou Medical University, Fifth Affiliated Hospital of Guangzhou Medical University, Shijiazhuang Obstetrics and Gynecology Hospital | Hemorrhage, Postpartum, Placenta Previa | 02/25 | 04/25 | | |
Liu, Zhaoming |
TRAPP, NCT05811676: Tranexamic Acid for the Prevention of Postpartum Hemorrhage in Pregnant Women with Placenta Previa |
|
|
| Recruiting | 3 | 1680 | RoW | Tranexamic acid, 0.9% sodium chloride | Guangzhou Medical University, Dongguan Maternal and Child Health Care Hospital, Foshan Women and Children Hospital, BoAi Hospital of Zhongshan, Women and Children's Hospital of Chongqing Medical University, Tianjin Central Hospital of Gynecology Obstetrics, Shandong Provincial Maternal and Child Health Care Hospital Affiliated to Qingdao University, Jinan, Urumqi Maternal and Child Health Care Hospital, Zhuhai Women and Children's Hospital, The First Affiliated Hospital of Zhengzhou University, Hunan Provincial Maternal and Child Health Care Hospital, Dalian women and children's medical group, Nanfang Hospital, Southern Medical University, Huadu District People's Hospital of Guangzhou, Northwest Women's and Children's Hospital, Xi'an, Shaanxi, First Affiliated Hospital, Sun Yat-Sen University, Shenzhen Maternity & Child Healthcare Hospital, Shenzhen Baoan Women's and Children's Hospital, Dongguan People's Hospital, First Affiliated Hospital of Xinjiang Medical University, Tongji Hospital, Peking Union Medical College, Peking University First Hospital, The First Affiliated Hospital of Guangzhou Medical University, Second Affiliated Hospital of Guangzhou Medical University, Fifth Affiliated Hospital of Guangzhou Medical University, Shijiazhuang Obstetrics and Gynecology Hospital | Hemorrhage, Postpartum, Placenta Previa | 02/25 | 04/25 | | |
Li, Haoran |
TRAPP, NCT05811676: Tranexamic Acid for the Prevention of Postpartum Hemorrhage in Pregnant Women with Placenta Previa |
|
|
| Recruiting | 3 | 1680 | RoW | Tranexamic acid, 0.9% sodium chloride | Guangzhou Medical University, Dongguan Maternal and Child Health Care Hospital, Foshan Women and Children Hospital, BoAi Hospital of Zhongshan, Women and Children's Hospital of Chongqing Medical University, Tianjin Central Hospital of Gynecology Obstetrics, Shandong Provincial Maternal and Child Health Care Hospital Affiliated to Qingdao University, Jinan, Urumqi Maternal and Child Health Care Hospital, Zhuhai Women and Children's Hospital, The First Affiliated Hospital of Zhengzhou University, Hunan Provincial Maternal and Child Health Care Hospital, Dalian women and children's medical group, Nanfang Hospital, Southern Medical University, Huadu District People's Hospital of Guangzhou, Northwest Women's and Children's Hospital, Xi'an, Shaanxi, First Affiliated Hospital, Sun Yat-Sen University, Shenzhen Maternity & Child Healthcare Hospital, Shenzhen Baoan Women's and Children's Hospital, Dongguan People's Hospital, First Affiliated Hospital of Xinjiang Medical University, Tongji Hospital, Peking Union Medical College, Peking University First Hospital, The First Affiliated Hospital of Guangzhou Medical University, Second Affiliated Hospital of Guangzhou Medical University, Fifth Affiliated Hospital of Guangzhou Medical University, Shijiazhuang Obstetrics and Gynecology Hospital | Hemorrhage, Postpartum, Placenta Previa | 02/25 | 04/25 | | |
NCT06102902: Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer |
|
|
| Recruiting | 1 | 30 | US | BET Bromodomain Inhibitor ZEN-3694, BETi ZEN-3694, ZEN 3694, ZEN-3694, ZEN003694, Biopsy, BIOPSY_TYPE, Bx, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Cetuximab, C 225, C-225, C225, Cetuximab Biosimilar CDP-1, Cetuximab Biosimilar CMAB009, Cetuximab Biosimilar KL 140, Chimeric Anti-EGFR Monoclonal Antibody, Chimeric MoAb C225, Chimeric Monoclonal Antibody C225, Erbitux, IMC-C225, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Echocardiography, EC, Encorafenib, Braftovi, LGX 818, LGX-818, LGX818, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Multigated Acquisition Scan, Blood Pool Scan, Equilibrium Radionuclide Angiography, Gated Blood Pool Imaging, Gated Heart Pool Scan, MUGA, MUGA Scan, Multi-Gated Acquisition Scan, Radionuclide Ventriculogram Scan, Radionuclide Ventriculography, RNV Scan, RNVG, SYMA Scanning, Synchronized Multigated Acquisition Scanning | National Cancer Institute (NCI) | Metastatic Colorectal Adenocarcinoma, Recurrent Colorectal Adenocarcinoma, Refractory Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8 | 06/25 | 06/25 | | |